BioSpace News Archive

Peijia Medical (HK Stock Code: 09996) successfully commenced the animal experiment for its mitral valve edge-to-edge repair product, advancing the development to the next stage. The commencement of this experiment reflects Peijia Medical’s long term commitment in developing independent intellectual property products. Rather than a “

Abcam, a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility in Fremont, CA, which will serve as a major new site for its specialist cell engineering team.

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced that the first patient has been dosed in the Phase 2b SOOTHE trial of BLU-5937, the Company

Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications Vault CTMS and Vault eTMF provide complete visibility into trials, enabling CRO to deliver value-added services to sponsors

Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global supply scale of cGMP nature-sourced psilocybin

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced that it has entered into a Common Stock Purchase Agreement with Tumim Stone Capital, LLC.

Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions. With this transaction, Centene will continue to digitize the administration of healthcare and accelerate innovation and modernization across the enter

- Reduction of marrow blasts observed in all evaluable patients - - Marrow complete response observed in 2 patients - - Management to host virtual KOL event today, Tuesday, December 8 at 8:00 a.m. ET -

NorthShore University HealthSystem (NorthShore) has joined researchers at Johns Hopkins Medicine to test the effectiveness of convalescent blood plasma outpatient treatments

Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced the appointment of John Ayres to the position of Vice President of Corporate Development and General Counsel.